CAMBRIDGE, UK: In a double revelation that could rewrite the playbook for future pandemics, scientists have made two startling discoveries about the human immune system, one reassuring, one deeply revealing.
First, current COVID-19 booster shots, despite struggling against today’s highly evolved variants, unexpectedly pack a punch against animal coronaviruses that have not yet jumped to humans. Second, the very first viral infection a person encounters in their lifetime permanently imprints itself on their immune system, shaping their defenses for years, perhaps decades, to come.
Covid-19 vaccine boosters offer surprise defense https://t.co/KrDHLJK601
— Anees Hanif (@anees_avis) July 2, 2026
Both findings, published today in npj Vaccines and iScience, offer a glimpse into a future where vaccines are no longer reactive but proactive,designed not just to chase evolving human variants but to preemptively guard against the next animal-to-human spillover before it even begins.
Surprising cross-protection discovered
A team from the University of Cambridge Institute for Therapeutic Immunology & Infectious Disease (CITIID) analysed blood samples from older individuals who had received four doses of a COVID-19 vaccine, including the bivalent booster. Their mission was to measure how well these antibodies neutralized emerging human variants.
The results were sobering, yet unexpectedly promising. While the booster-generated antibodies showed minimal power against newer, heavily evolved Omicron subvariants, they proved remarkably effective at neutralising a group of coronaviruses known as sarbecoviruses, found in bats and pangolins.
These viruses have not yet made the leap to humans, but they carry the potential to spark the next pandemic.
“We were surprised to find that the vaccine provides protection against some animal coronaviruses with future pandemic potential,” said Dr. Grace West of CITIID, jointly first author of the npj Vaccines paper. “This could offer us some first line defense should there be an animal-to-human coronavirus spillover event and buy us precious time to develop appropriate therapies.”
The discovery suggests that even imperfect vaccines can act as a critical buffer, slowing the spread of a novel virus and giving global health systems a fighting chance to respond before disaster unfolds.
The permanent mark of ‘immune imprinting’
In a parallel study, Cambridge researchers collaborated with scientists in Nigeria to explore how the sequence of viral exposures shapes long-term immune responses. By studying individuals who were unvaccinated against COVID-19 but had contracted the original strains naturally, they confirmed a phenomenon long theorized but now proven: immune imprinting is permanent.
Simply put, the immune system “does not start again from zero” when confronted with a new variant or an updated vaccine. Instead, the very first viral infection a person suffers leaves an indelible mark,a molecular memory that biases the body’s future responses.
When exposed to an evolved virus or a new vaccine, the immune system remains “predisposed to mount primarily the immune response against the initial infection.”
This explains why the COVID-19 booster offers significant defense against bat and pangolin sarbecoviruses. These animal coronaviruses have spike proteins that are structurally similar to the original SARS-CoV-2 strain, far less evolved than the heavily mutated Omicron variants we face today. The immune system, imprinted by that first encounter, recognizes and responds vigorously to what looks familiar.
A paradigm shift for next-generation vaccines
Together, these dual findings signal a turning point in vaccine strategy. Global health leaders are now advocating for “pan-coronavirus” vaccines, shots designed not to chase the latest human variant but to target shared, unmutated regions of the spike protein common across multiple viral families.
By doing so, next-generation vaccines could achieve two goals simultaneously:
- Overriding immune imprinting, ensuring that new exposures generate fresh, effective responses rather than recycled, outdated ones.
- Broadening defence against emerging wildlife threats, creating a universal shield that could neutralize future spillover viruses before they gain a foothold in human populations.
“The era of simply updating boosters for the latest strain may be coming to an end,” noted a senior researcher involved in the studies. “The future lies in vaccines that anticipate, rather than react, protecting us not just from what we know, but from what we fear is coming next.”
